TWST Twist Bioscience Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: TWST

Price (delayed)

$153.1

Market cap

$9.6B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.22

Enterprise value

$9.59B

?
Relative Growth: Rel. Growth: 42
Relative Strength: Rel. Strength: 99
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 20

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of ...

Highlights
TWST's gross profit is up by 26% year-on-year and by 5% since the previous quarter
TWST's revenue is up by 19% YoY and by 5% from the previous quarter
Twist Bioscience's debt has increased by 17% YoY but it has decreased by 2% from the previous quarter
The net income has shrunk by 68% QoQ and by 60% YoY
TWST's EPS has dropped by 68% since the previous quarter and by 54% year-on-year
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.twistbioscience.com
Peers: NVAX NVCR NBIX

Key stats

What are the main financial stats of TWST

TWST stock price

How has the Twist Bioscience stock price performed over time
Intraday
2.03%
1 week
12.3%
1 month
76.91%
1 year
463.07%
YTD
382.66%
QTD
48.81%

Financial performance

How have Twist Bioscience's revenue and profit performed over time
Revenue
$431.8M
Gross profit
$224.39M
Operating income
-$144.98M
Net income
-$136.72M
Gross margin
52%
Net margin
-31.7%
The net income has shrunk by 68% QoQ and by 60% YoY
Twist Bioscience's net margin has plunged by 60% from the previous quarter and by 35% YoY
TWST's gross profit is up by 26% year-on-year and by 5% since the previous quarter
TWST's revenue is up by 19% YoY and by 5% from the previous quarter

Price vs fundamentals

How does TWST's price correlate with its fundamentals

Growth

What is Twist Bioscience's growth rate over time

Valuation

What is Twist Bioscience stock price valuation
P/E
N/A
P/B
21.39
P/S
22.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
22.21
TWST's EPS has dropped by 68% since the previous quarter and by 54% year-on-year
TWST's P/B is 197% above its last 4 quarters average of 7.2
Twist Bioscience's equity has decreased by 7% YoY and by 2.1% QoQ
TWST's P/S is 180% above its last 4 quarters average of 7.9 and 113% above its 5-year quarterly average of 10.4
TWST's revenue is up by 19% YoY and by 5% from the previous quarter

Efficiency

How efficient is Twist Bioscience business performance
The return on equity has dropped by 71% since the previous quarter and by 63% year-on-year
The ROA has plunged by 66% from the previous quarter and by 51% YoY
TWST's return on sales has dropped by 60% since the previous quarter and by 35% year-on-year
Twist Bioscience's ROIC has plunged by 59% from the previous quarter and by 21% YoY

Dividends

What is TWST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TWST.

Financial health

How did Twist Bioscience financials performed over time
Twist Bioscience's total assets is 197% higher than its total liabilities
TWST's quick ratio is down by 44% year-on-year and by 2% since the previous quarter
Twist Bioscience's total liabilities has increased by 37% YoY and by 2.5% QoQ
Twist Bioscience's debt is 76% less than its equity
Twist Bioscience's debt to equity has increased by 26% YoY
Twist Bioscience's debt has increased by 17% YoY but it has decreased by 2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.